Member Info for ratcliffewriter

'A 2 million cash burn is nothing'? Unless it happens to represent over 40 percent of the company's entire market capital, and the bulk of it is spent on wages.

As for 201 phase 2 trial being 'completed', they might have a hope of that if they'd actually started. 201 has been gathering dust for almost 3 and a half years. It looks more like the Norwegian Blue parrot than anything else.

30th November 2020 (almost 3 and a half years ago) on the full results from 201 - 'Additional detailed analysis of the results will form the basis of peer-reviewed journal publications.'

You're the enthusiast, I'm the potential investor. Where is the 'additional detailed analysis? Where are the peer reviews? You say 201 is some sort of transformational game changer, I think it's a dead duck. Convince me otherwise, because for now you just look like a soot-juggling ramper trying to pump this to reduce losses.

'The science work.....has been really good.'

Can you give me a summary of scientific progress over the last 24 months, preferably with links to RNSs and peer reviews?

'Val does not do clinical trials.'

True PM. Does Val do anything at all these days?

A lot of hypothesis and a slight absence of facts from you PM.

'... if they use the money wisely..'

'... If the merger completes'

....hopefully

......maybe

.... If the cash runway allows....

.....if we have 401/201 signed

......avoiding a large dilution. (Yet another one, you mean)

Not a ramp (Thanks for making that clear, many will have thought otherwise)

... It simply needs one or two events to happen (Some of which are already three years late, but at least we cut out one hour this morning)

Private dental care isn't cheap in Transylvania either.

More likely Dracula...

Bojo - obviously correct re the perpetuation of an extremely old thread. I've just seen his latest reply. Very much the morning after the night before.

It's purely stirring as everyone can see - he spent yesterday evening posting the exact same thing on AVCT, VAL, DEST, PREM, VAST, GCM, QED and BLVN as well as SCLP.

I suppose that's what happens to him when he's got no friends and his p ornhub direct debit gets rejected.

'Forget Black Cat.'

So that was just broken promises and a bad idea was it?

The foundations are NOT very strong. FACT.

IF 201 is signed....if

If 401 completes....if

....about 30/40 million due to the milestones attached from the deals. (What deals? Pure fantasy guesswork)

.....a huge deal in the next two years maybe...(maybe, maybe not)

The EUDA merger looks on.... (based on?)

Anyway, with my next 10 million investment I'm going to make half a billion. If I win the Euromillions that is. Provided I buy a ticket of course.

I've never offered any opinion on SD if you care to look. I'm just saying that they need an income stream and soon, and taking on work without pay is not the way to go. The track record of deadlines is truly abysmal, and while scientifically this latest RNS may be interesting, it will take time and effort which cost money they simply can't spare.

I'd rather see an update on Black Cat (you may be too young to remember the 5 million they were going to source) and on 201 (poor results on clinically insinificant numbers and static for several years since without a peer review) and some news on TheoremRx (silent since Adam was a lad) would be a lot more welcome. They need to get their priorities in order and soon.

"This signifies an exciting opportunity for ValiRx to further expand its portfolio of innovative cancer therapeutics", all of which to date appear unloved, stagnant and a financial desert. This latest rns means that however interesting, time will be spent paying people not to generate revenue over a minimum of 12 months - and do they mean Val months or earth months. Because 12 Val months seem to equate to about 36 earth months or more.

Still not an incentive to buy shares here. The crew are now engaged in rearranging the deck chairs on the Titanic while they discuss who they want to be Captain, assuming they can find a volunteer on what will have to be a pretty low salary. I'll guess some fanfare appointment in a couple of months to support a(nother) raise.

The resurrected post to which PM objects is only a couple of weeks older than the 2nd November 2021 RNS which said of the 'deal' with Theoremrx 'The first payments are expected by the end of 2021.'

So the LOI and TheoremRx dealings are by your definition irrelevant. I have to agree with you on that basis.

Now he's assuming other people's gender. (Presuming he's also actually a he and not an amoeboid zingatularian or something)

That's like saying 'her twitter account has gone and rumour is she'll be resigning quite soon.'

SD's Twitter/X account seems to have disappeared. Is this significant? It leaves me somewhat devoid of confidence and concerned.

If they work it hard it could get the bid to just around 33 percent below the last raise price. Would that be a cause for rejoicing...?

Apologies, remember it now. It's an age thing probably.

When was it £1.40?